1. Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio
- Subjects
Merck & Company Inc. -- Forecasts and trends -- Growth ,AbbVie Inc. -- Forecasts and trends -- Growth ,Bristol-Myers Squibb Co. -- Forecasts and trends -- Growth ,Pfizer Inc. -- Forecasts and trends -- Growth ,Viatris Inc. -- Forecasts and trends -- Growth ,AstraZeneca PLC -- Forecasts and trends -- Growth ,F. Hoffmann-La Roche Ltd. -- Forecasts and trends -- Growth ,Teva Pharmaceutical Industries Ltd. -- Forecasts and trends -- Growth ,Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends -- Growth ,Sanofi S.A. -- Forecasts and trends -- Growth ,Bayer AG -- Forecasts and trends -- Growth ,Johnson & Johnson -- Forecasts and trends -- Growth ,Cipla Ltd. -- Forecasts and trends -- Growth ,Gilead Sciences Inc. -- Forecasts and trends -- Growth ,GSK PLC -- Forecasts and trends -- Growth ,Novartis AG -- Forecasts and trends -- Growth ,Sun Pharmaceutical Industries Ltd. -- Forecasts and trends -- Growth ,Biological products industry -- Forecasts and trends -- Growth -- Health aspects ,Biotechnology industry -- Forecasts and trends -- Growth -- Health aspects ,Pharmaceutical industry -- Forecasts and trends -- Growth -- Health aspects ,Company growth ,Market trend/market analysis ,Business ,News, opinion and commentary - Abstract
NEW YORK, Jan. 23, 2024 /PRNewswire/ --Thehttps://c212.net/c/link/?t=0&l=en&o=4073502-1&h=3106611694&u=https%3A%2F%2Fwww.technavio.com%2Freport%2Fhospital-infection-therapeutics-market-analysis%3Futm_source%3Dprnewswire%26utm_medium%3Dprnewswire%26utm_campaign%3Dlatest_T47_wk04_2024_019_rep%26utm_content%3DIRTNTR75007&a=hospital+infection+therapeutics+market is estimated to grow byUSD 3.10 billion from 2022 to 2027, growing at aCAGR of 4.98%, according to Technavio.Special drug designations are a [...]
- Published
- 2024